Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study. [electronic resource]
Producer: 20040106Description: 257-65 p. digitalISSN:- 0167-6806
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Epirubicin -- administration & dosage
- Female
- Fever -- chemically induced
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Middle Aged
- Nausea -- chemically induced
- Neutropenia -- chemically induced
- Taxoids -- administration & dosage
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.